Drug target and biomarker for multiple sclerosis

— Technology Description

Researchers in Prof. Robyn Klein’s laboratory have discovered that interferon lambda (IFN-λ) is a potential target for treating multiple sclerosis (MS), particularly secondary progressive MS (SPMS).

Most patients with MS present with relapsing remitting MS (RRM…

S1PR2-targeted PET tracers

— Technology Description

Researchers at Washington University in St. Louis and colleagues have developed S1PR2-targeted PET tracers. Sphingosine-1-phosphate (S1P) is an important bioactive lipid that regulates critical biological functions by acting through five specific G protein-coupled S1P recept…

Create a Collection
Creating...